Select Publications
Book Chapters
2024, 'Alternative klinische Studiendesigns für die Nephrologieforschung', in Innovationen in der Nephrologie, Springer Nature Switzerland, pp. 513 - 550, http://dx.doi.org/10.1007/978-3-031-65236-3_28
,2022, 'Alternative Clinical Trial Designs for Nephrology Research', in Innovations in Nephrology: Breakthrough Technologies in Kidney Disease Care, pp. 461 - 492, http://dx.doi.org/10.1007/978-3-031-11570-7_28
,2022, 'Dialysis Dose and Adequacy for Hemodialysis', in Evidence-Based Nephrology, Second Edition: Volumes 1,2, pp. 20 - 33, http://dx.doi.org/10.1002/9781119105954.ch41
,2014, 'Acute dialysis in older patients', in Managing Renal Injury in the Elderly Patient, pp. 59 - 71, http://dx.doi.org/10.1007/978-3-642-39947-3_7
,2014, 'Kidney Disease in Diabetes', in Managing Cardiovascular Complications in Diabetes, pp. 58 - 86, http://dx.doi.org/10.1002/9781118337967.ch3
,2012, 'Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease', in Wang Y (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd009631
,2011, 'Interventions for preventing intradialytic hypotension in haemodialysis patients', in Gangadharan Komala M (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd009459
,2010, 'Antiplatelet agents for chronic kidney disease', in Palmer SC (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd008834
,